Skip to main content
logo
Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.5015
-0.0395 (-7.30%)
At close: Aug 14, 2026, 4:00 PM EDT
0.6259
+0.1244 (24.81%)
After-hours: Aug 14, 2026, 7:59 PM EDT

Skye Bioscience Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-57.33-55.92-26.57-37.64-19.48-8.52
Depreciation & Amortization
0.720.720.30.120.110.03
Other Amortization
--0.60.330.490.59
Loss (Gain) From Sale of Assets
-0.35-0.36-1.350.3--
Asset Writedown & Restructuring Costs
---21.22--
Stock-Based Compensation
7.067.778.320.990.630.87
Other Operating Activities
---3.911.26.27-0.1
Change in Accounts Payable
2.081.4-0.59-0.70.80.52
Change in Other Net Operating Assets
5.383.34-2.040.23-1.560.13
Operating Cash Flow
-42.43-43.06-25.24-13.95-12.74-6.47
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0.01-1.6-0.01-0.09-0.09
Sale of Property, Plant & Equipment
0.360.361.365.53--
Cash Acquisitions
---1.085.31-
Investment in Securities
3.84-19.85----
Investing Cash Flow
4.2-19.5-0.256.65.21-0.09

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---4.97--
Long-Term Debt Issued
----0.68-
Total Debt Issued
---4.970.68-
Long-Term Debt Repaid
----0.26-0.89-
Net Debt Issued (Repaid)
-0.07--4.71-0.21-
Issuance of Common Stock
--9012014.01
Other Financing Activities
0.030.03-6.43-0.27--0.94
Financing Cash Flow
-0.040.0383.5616.44-0.2113.08

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-38.27-62.5358.089.09-7.746.51

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-42.43-43.07-26.84-13.96-12.84-6.57
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.07-1.09-0.74-1.99-5.78-4.04
Levered Free Cash Flow
-21.83-22.95-9.05-11.04-9.44-3.28
Unlevered Free Cash Flow
-21.83-22.95-9.18-10.8-9.51-3.39

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0-0.430.20.330.04
Cash Income Tax Paid
00.010.0100.010
Change in Working Capital
7.474.73-2.63-0.47-0.760.65
SEC Filings: 10-K · 10-Q